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INTRODUCTION
Cervical cancer is the fourth most common cause of 
cancer related deaths in developed countries and the 
second most common cause in the third world countries 
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Objective: To evaluate the feasibility of a parameter-free intravoxel incoherent motion (IVIM) approach in cervical cancer, 
to assess the optimal b-value threshold, and to preliminarily examine differences in the derived perfusion and diffusion 
parameters for different histological cancer types.
Materials and Methods: After Institutional Review Board approval, 19 female patients (mean age, 54 years; age range, 37–78 
years) gave consent and were enrolled in this prospective magnetic resonance imaging study. Clinical staging and biopsy 
results were obtained. Echo-planar diffusion weighted sequences at 13 b-values were acquired at 3 tesla field strength. Single-
sliced region-of-interest IVIM analysis with adaptive b-value thresholds was applied to each tumor, yielding the optimal fit 
and the optimal parameters for pseudodiffusion (D*), perfusion fraction (Fp) and diffusion coefficient (D). Monoexponential 
apparent diffusion coefficient (ADC) was calculated for comparison with D.
Results: Biopsy revealed squamous cell carcinoma in 10 patients and adenocarcinoma in 9. The b-value threshold (median 
[interquartile range]) depended on the histological type and was 35 (22.5–50) s/mm2 in squamous cell carcinoma and 150 
(100–150) s/mm2 in adenocarcinoma (p < 0.05). Comparing squamous cell vs. adenocarcinoma, D* (45.1 [25.1–60.4] x 10-3 
mm2/s vs. 12.4 [10.5–21.2] x 10-3 mm2/s) and Fp (7.5% [7.0–9.0%] vs. 9.9% [9.0–11.4%]) differed significantly between the 
subtypes (p < 0.02), whereas D did not (0.89 [0.75–0.94] x 10-3 mm2/s vs. 0.90 [0.82–0.97] x 10-3 mm2/s, p = 0.27). The 
residuals did not differ (0.74 [0.60–0.92] vs. 0.94 [0.67–1.01], p = 0.32). The ADC systematically underestimated the 
magnitude of diffusion restriction compared to D (p < 0.001).
Conclusion: The parameter-free IVIM approach is feasible in cervical cancer. The b-value threshold and perfusion-related 
parameters depend on the tumor histology type.
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(1). Recent advances in preventive medicine, namely 
human papillomavirus (HPV) vaccination and HPV-screening 
programs, have led to increased protection against cervical 
cancer (2). In diagnostics, there is a growing interest in the 
use of magnetic resonance imaging (MRI) for local staging 
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(3). While patients with low-grade, locally confined tumors 
(Fédération de Gynécologie et d’Obstétrique [FIGO] stages 
IB1 and IIA1) may be amenable to surgical resection alone, 
advanced tumors require combined radio-chemotherapy 
(4). MRI not only provides detailed anatomical information 
but is also able to deliver functional information, e.g., 
about tissue diffusivity in diffusion weighted imaging 
(DWI). A promising approach is the intravoxel incoherent 
motion imaging (IVIM) analysis, which attempts to 
separate perfusion from true diffusion effects. In other 
words, the signal decay is described by a biexponential 
instead of a monoexponential equation which yields a more 
accurate description of the underlying tissue properties 
(5). IVIM has recently been shown to differentiate among 
histopathological tumor types, and, in addition, correlates 
with tumor grades of cervical cancer (6, 7).
Intravoxel incoherent motion imaging exploits a so-
called “pseudodiffusion-effect” which corresponds to fast 
moving water molecules in the capillaries (5). This effect 
will, typically at low b-values (< 150 s/mm2, though the 
exact threshold depends on the tissue), superimpose 
the signal decay caused by true diffusion. In the brain 
and kidney, IVIM derived perfusion parameters were 
reported to correlate with the blood flow measured in-
vivo and ex-vivo (8). However, the conventional segmented 
biexponential fitting approach entails arbitrarily setting a 
b-value threshold for separating diffusion from perfusion 
decay (9). This requires a priori knowledge about the 
magnetization decay in the target tissue, and entails 
the danger of introducing a faulty physical property into 
the tissue analysis. In turn, an arbitrarily high or low 
b-value threshold will influence the derived diffusion 
and perfusion parameters (10) and create a potential 
confounder. A recently published parameter-free (i.e., with 
no a priori fixed parameters) IVIM fitting algorithm has 
shown promising results in the abdominal organs, yielding 
more stable perfusion and diffusion characterization of 
the liver, spleen, pancreas and kidney without the need of 
setting a b-value threshold (10). The algorithm has since 
been verified in neuroimaging as well (11). The algorithm 
essentially consists of computing an IVIM-fit for each 
b-value, one at a time. This will yield one possible curve or 
‘fit-candidate’ for each acquired b-value (except the highest 
one, as explained below). By mathematically determining 
the best fit from those candidates, defined as the smallest 
sum of squared residuals to the curve/fit, one receives an 
optimal b-value threshold in addition to the “classical” 
IVIM parameters. Hence, under this paradigm, the b-value 
threshold is interpreted as an additional variable tissue 
specific marker.
The purpose of this study was to evaluate the feasibility 
of a parameter-free IVIM approach in cervical cancer, to 
assess the optimal b-value threshold, and to preliminarily 
examine differences in the derived perfusion and diffusion 
parameters for different histological cancer types.
MATERIALS AND METHODS
Patients
This prospective clinical study was approved by the 
local Institutional Review Board. After oral and written 
consent, 19 female patients (mean age, 54 years; range, 
37–78 years) with biopsy-proven cervical cancer examined 
between June 2014 and December 2015 were enrolled. 
None of the patients had received prior treatment. Inability 
to cooperate, incomplete or non-diagnostic MRI scan were 
dropout criteria. Clinical FIGO stage was obtained from the 
patient’s record.
Histopathological Analysis
Histopathological specimens were assessed by an 
experienced gynecological pathologist for tumor type and 
grade (G1–G3) and were subsequently reviewed at the 
weekly multi-disciplinary meeting.
Imaging Protocol
All patients were scanned on a clinical 3-tesla MRI scanner 
(Achieva 3T, Philips Healthcare, Best, the Netherlands), 
using a 16-channel phased array torso coil. Patients fasted 
for 6 hours prior to the examination and received 20 mg 
hyoscine butylbromide (Buscopan; Boehringer Ingelheim, 
Ingelheim am Rhein, Germany) as an intramuscular injection 
immediately before scanning to reduce bowel peristalsis. 
Diffusion datasets of the pelvis were acquired with a single-
shot spin-echo echo-planar imaging sequence in axial 
orientation (20 slices) to include the entire cervical cancer 
using 13 b-values as suggested by Koh et al. (12): 0, 10, 
20, 30, 40, 50, 75, 100, 150, 300, 500, 800, 1000 s/mm2, 
in three orthogonal directions. Sequences were acquired in 
free breathing, and fat suppression was achieved by spectral 
presaturation with inversion recovery. Total scan time for 
the IVIM-sequence was approximately 6 minutes 30 seconds. 
Anatomical T1- and T2-weighted sequences, as summarized 
in Table 1, were acquired separately from the IVIM-sequence.
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Region-of-Interest Definition
For the analysis, polygonal regions-of-interest (ROI) 
in the tumor and in the gluteus maximus muscle were 
manually defined on the b = 0 s/mm2 (b0) image depicting 
the largest tumor diameter, and subsequently copied to 
the same position on the images of the remaining b-values 
of the same dataset. Necrotic areas, as well as prominent 
vessels, were avoided in order to assess only the actual 
tumor tissue. The absence of necrotic and vessel areas, 
as well as absence of obvious artifacts, was verified for 
all b-values. ROI definition was performed by a radiology 
resident and verified by a board-certified radiologist with 7 
years of experience in genitourinary imaging. An exemplary 
ROI definition is shown in Figure 1. The obtained signal 
intensity curves were normalized to arbitrary units with the 
maximum value 1 at b0.
For intra-reader agreement, the initial reader re-performed 
the ROI definition > 4 months after the initial analysis. For 
inter-reader agreement, a 2nd radiologist not involved in 
the original ROI definition, performed the same analysis 
independently.
IVIM Analysis
All IVIM-analyses were performed with optimized in-
house MATLAB (Release 2015b, MathWorks, Natick, MA, 
USA) computer programs.
The IVIM approach tries to separate perfusion and 
diffusion effects in the signal decay by describing the decay 
with the following biexponential equation (Equation 1):
Sb/S0 = (1-Fp)exp(-bD) + Fp exp(-bD*)
Sb represents the signal at a given b-value, S0 the signal 
at the b-value 0 s/mm2, D the true molecular diffusion, D* 
the pseudodiffusion, and Fp the relative perfusion fraction.
The algorithm to compute the optimal b-value threshold 
and IVIM parameters is an extension of the adaptive b-value 
biexponential fitting, and has been published in detail 
before (10). In short, the following steps were performed:
I. Calculation of D from the highest n b-values with 
the assumption that perfusion contributions to the signal 
Table 1. Summary of MRI Scan Parameters
Sequences T2W TSE T2W TSE SPAIR T2 TSE T2W TSE DWI CE T1W-THRIVE
Plane Sagittal Coronal Axial Oblique axial Axial 3D
TR/TE (ms) 4000/80 3500/80 2800/100 2800/100 2000/54 3/1.4
Turbo factor 30 21 12 14 NA NA
FOV (mm) 240 x 240 230 x 230 402 x 300 220 x 220 406 x 300 370 x 203
Matrix size 480 x 298 352 x 300 787 x 600 316 x 311 168 x 124 248 x 134
Slice thickness (mm) 4 4 4 4 4 1.5
Intersection gap (mm) 0 0 0 0 0 0
Bandwidth (Hz/pixel) 230 186 169 162 15.3 724
NEX 2 1 1 1 2 1
CE = contrast-enhanced, DWI = diffusion-weighted imaging, FOV = field of view, NEX = number of excitation, SPAIR = spectral attenuated 
inversion recovery, THRIVE = T1W high resolution isotropic volume examination, TR/TE = repetition time/echo time, TSE = turbo spin echo
Fig. 1. ROI definition. Top left panel: screenshot of exemplary ROI 
definition in zoomed section of b0 image (top row, middle). Remaining 
panels: diffusion signal decay series at single slice position of 53-year-
old patient with adenocarcinoma arising from cervix. ROI = region of 
interest
b = 800 s/mm2 b = 1000 s/mm2
b = 20 s/mm2 b = 30 s/mm2 b = 40 s/mm2
b = 50 s/mm2 b = 75 s/mm2 b = 100 s/mm2
b = 150 s/mm2 b = 300 s/mm2 b = 500 s/mm2
b = 0 s/mm2 b = 10 s/mm2
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decay are negligible at high b-values. First, n is equal to 
the number of all available b-values. D is calculated using 
a first-order polynomial fit to the log-transformed signal 
intensities (Equation 2):
logSb = -D x b + logS’0
II. Calculation of Fp from the measured signal intensity at 
b = 0 (S0) and the derived S0’ (Equation 3):
Fp =
 S0 - S0’
         S0
III. Calculation of D* (using the computed values for D 
and Fp as fixed factors) for all b-values by fitting the signal 
intensities to Equation 1 using a non-linear least-squares 
algorithm based on the Levenberg-Marquardt technique. The 
corresponding MATLAB function “lsqcurvefit” also provides 
the sum of the squared residuals to the fit.
IV. Steps I–III are repeated with the next lower b-value 
dropped in step I and II to determine the initial D and Fp. 
Thus, the algorithm will loop n-1 times (n = number of 
b-values). In the end, only the two highest b-values remain 
(for the highest b-value alone no polynomial fit can be 
calculated).
V. Finally, the optimal b-value threshold and 
corresponding IVIM-parameters are determined by 
determining the fit with the lowest number of squared 
residuals from step III, mathematically corresponding to the 
best fit to the measured signal intensities. 
An illustration of several fits from the step-wise fitting 
process is depicted in Figure 2. 
Furthermore, a conventional monoexponential apparent 
diffusion coefficient (ADC) was computed from two b-values 
(0 and 800 s/mm2) for comparison with D.
In addition to the ROI analysis, voxel-wise IVIM analysis 
of the selected slices was done to generate parametrical 
b-value threshold, Fp-, D-, and D*-maps of the whole 
examined region as a visual instrument to verify the 
quantitative measurements obtained by the ROI analysis.
Statistical Analysis
Statistical analysis was performed using R version 
3.2.4. (R Foundation for Statistical Computing, Vienna, 
Austria). Medians and interquartile ranges (IQR) of the IVIM 
parameters Fp, D, and D* as well as the optimal b-value 
threshold, defined as the b-value threshold resulting in 
the fit with the smallest sum of squared residuals, were 
computed for muscle, squamous cell carcinomas and for 
adenocarcinomas. Intra- and inter-reader agreements 
were assessed with a weighted Cohen’s kappa (κ). The κ 
scores were interpreted as follows: slight (κ < 0.20), fair 
(κ = 0.20–0.39), moderate (κ = 0.40–0.59), substantial 
(κ = 0.60–0.79), or excellent (κ > 0.80) agreement (13). 
Correlations were assessed with a Pearson correlation 
coefficient for the clinical FIGO stage and histological 
differentiation. Since normality for the calculated 
parameters could not be assumed, the results were 
Fig. 2. Example signal decay with fitted curve candidates at different b-value thresholds (dotted lines). 
Best fit, i.e., curve with smallest sum of squared residuals, is drawn as continuous line (b-value threshold = 150 s/mm2 in (A), and 10 s/mm2 in 
(B)). One sample of adenocarcinoma is shown in (A), sample of squamous cell carcinoma is shown in (B). Signal is given in arbitrary units (AU) 
normalized to maximum of 1 and minimum of 0.
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compared with a Wilcoxon rank sum test. A significance 
level of p < 0.05 was considered statistically significant, 
and p values were corrected for multiple comparisons with 
the Benjamini-Hochberg procedure (14). Significantly 
different parameters were further assessed with a receiver 
operator characteristics (ROC) analysis. All plots including 
an exemplary fitting process were plotted with ggplot2 (15) 
from the MATLAB output.
RESULTS
There were 7 patients with a FIGO-stage I, 8 patients 
with a stage II, and 4 patients with a stage III tumor. Ten 
patients had squamous cell carcinomas, and 9 patients 
had adenocarcinomas. Only 2 patients had low-grade 
tumors (G1, well differentiated); 7 patients, intermediate 
(G2, moderately differentiated); 2 patients, intermediate 
to high (G2–3); and 4 patients, high-grade (G3, poorly 
differentiated) tumors. Accurate grading was not possible in 
4 tumors (GX).
Image acquisition and post-processing were successfully 
completed for all patients.
Intra-reader agreement was substantial for D {κ = 0.79 
(95% confidence interval [CI]: 0.57–1.0)} and moderate for 
Fp (0.50 [0.15–0.84]) and D* (0.57 [0.21–0.93]). Similarly, 
inter-reader agreement was substantial for D (κ = 0.67 [95% 
CI: 0.37–0.98] and moderate for Fp (0.53 [0.18–0.87]) and 
D* (0.52 [0.26–0.78]). 
The highest b-value threshold was found in the paraspinal 
muscle (median 500 s/mm2 [IQR: 40–500 s/mm2]), with 
a D = 1.40 (1.34–1.43) x 10-3 mm2/s, D* = 5.7 (5.2–25.7) 
x 10-3 mm2/s and Fp = 10.5% (8.1–12.3%). Squamous cell 
carcinomas, compared to adenocarcinomas, exhibited a 
significantly higher D* (45.1 [25.1–60.4] vs. 12.4 [10.5–
21.2] x 10-3 mm2/s, adjusted p = 0.03), lower Fp (7.5% 
[7.0–9.0%] vs. 9.9% [9.0–11.4%]) and lower b-value 
threshold (35 [22.5–50] s/mm2 vs. 150 [100–150] s/mm2, 
p = 0.03) (Table 2, Figs. 3, 4). The sum of squared residuals 
was not significantly different between the adenocarcinoma 
and the squamous cell carcinoma group (p = 0.3). 
Table 2. IVIM Parameters and Sum of Squared Residuals for Two Carcinoma Types and Muscle Tissue
D*
(x 10-3 mm2/s)
Fp (%)
D
(x 10-3 mm2/s)
b-Value Threshold
(s/mm2)
Residuals
Muscle 5.7 (5.2–25.7) 10.5 (8.1–12.3) 1.40 (1.34–1.43) 500 (40–500) 0.29 (0.18–0.62) 
Squamous cell carcinoma 45.1 (25.1–60.4) 7.5 (7.0–9.0) 0.89 (0.75–0.94) 35 (22.5–50) 0.74 (0.60–0.92)
Adenocarcinoma 12.4 (10.5–21.2) 9.9 (9.0–11.4) 0.90 (0.82–0.97) 150 (100–150) 0.94 (0.67–1.01)
Data are median (interquartile range). IVIM = intravoxel incoherent motion
Fig. 3. Boxplot of optimal b-value thresholds (defined as yielding smallest sum of squared residuals to fit, which are depicted on 
far right as “residuals”) and IVIM parameters D, D*, and Fp of two examined histological cancer types adenocarcinoma (Ad.) and 
squamous cell carcinoma (SCC). IVIM = intravoxel incoherent motion
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Although Pearson correlation testing initially showed 
promising results, namely D* and Fp correlating with the 
FIGO stage (correlation coefficient r = 0.51 and -0.48, 
respectively), the results have to be considered non-
significant after correcting for multiple comparisons 
(adjusted p = 0.08). Both the b-value threshold and D 
did not correlate significantly with either FIGO stage or 
histological grade (p > 0.05) (Table 3).
Receiver operator characteristics curve analysis 
demonstrated areas under the curve (Az) for Fp and D* of 0.82 
and 0.81, respectively, and 0.78 for the b-value threshold. 
The cutoff for Fp was 0.1 (sensitivity 50% [20–80%; 
bootstrapped 95%-CI], specificity 100%), for D* 37.8 x 
10-3 mm2/s (sensitivity, 60% [30–90%]; specificity, 100%) 
and for the b-value 75 s/mm2 (sensitivity, 80% [50–100%]; 
specificity, 77.8% [44–100%]). An illustration of the three 
ROC-curves is depicted in Figure 5.
The ADC derived from the monoexponential model (1.01 
[0.95–1.20] x 10-3 mm2/s) systematically underestimated 
the diffusion restriction compared to D (0.90 [0.84–0.95] x 
10-3 mm2/s, p < 0.001) due to contamination with perfusion 
Table 3. Results of Pearson Correlation Test for FIGO-Stages 
and Histological Grades
FIGO Stage Histologic Grades
r (D*) 0.51 0.30
p (D*) 0.03 0.28
ad-p (D*) 0.08 0.51
r (Fp) -0.48 -0.24
p (Fp) 0.04 0.38
ad-p (Fp) 0.08 0.51
r (D) -0.01 -0.14
p (D) 0.97 0.61
ad-p (D) 0.97 0.61
r (b-value threshold) -0.39 -0.47
p (b-value threshold) 0.10 0.08
ad-p (b-value threshold) 0.12 0.32
r = correlation coefficient; i.e., slope of correlation line; p = raw p 
value; ad-p = adjusted p; i.e., adjusted for multiple comparisons. 
FIGO = Fédération de Gynécologie et d’Obstétrique
Fig. 4. Parametric maps depicting three IVIM parameters D, D*, and Fp in one case of squamous cell carcinoma (SCC) in top 
row, and adenocarcinoma (Ad.) in bottom row (both outlined and marked with white arrow). Difference in Fp is subtle, but can be 
appreciated in right column with color scale set to maximum of 0.3 for this example. IVIM = intravoxel incoherent motion
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Fig. 5. Receiver operator characteristics curve of three IVIM 
derived parameters for differentiation of adenocarcinoma (Ad.) 
and squamous cell carcinoma (SCC). Az was 0.82 (Fp, D*) and 0.81 
(b-value threshold). IVIM = intravoxel incoherent motion
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related signal decay at low b-values (Supplementary 
Fig. 1 in the online-only Data Supplement). Although 
the difference between ADC and D tended to be larger 
in adenocarcinomas (0.17) compared to squamous cell 
carcinomas (0.11), this discrepancy was not significant (p = 
0.13).
DISCUSSION
This study found that the parameter-free IVIM approach 
is feasible in MRI of cervical cancer, and that the optimal 
b-value threshold lies between 20 and 150 s/mm2, but 
seems to be dependent on the histological type of the 
tumor. Squamous cell cancers cluster around 30 ± 20 s/mm2, 
and adenocarcinomas lean heavily towards the higher end of 
the spectrum at 150 s/mm2. In addition, D* and Fp differed 
significantly between the two histology types. The sum 
of squared residuals, however, did not differ significantly 
between the two types, suggesting that the derived IVIM 
parameters accurately described the measured signal 
decay. Moreover, the b-value thresholds in the paraspinal 
muscle are in line with previous reports (10), showing the 
relative stability of the algorithm across platforms. In the 
conventional segmented biexponential fitting approach 
with an a priori selected, fixed b-value threshold, D* tended 
to be “unstable” due to an arbitrarily chosen b-value 
that did not correspond to the true physical properties of 
the tissue, because the derived IVIM parameters depend 
heavily on the b-value threshold used (10). Previously, 
D* did not even allow for differentiation between normal 
and cancerous tissue because of its high variability (7). 
The present finding that the ADC tends to underestimate 
perfusion restriction is consistent with results of a more 
extensive study demonstrating that parameters derived 
from a monoexponential model are clearly inferior in 
the differentiation of cervical cancer when compared to 
parameters from biexponential models such as IVIM (16). 
This implies that a reliable IVIM algorithm is of particular 
interest for cervical carcinoma.
Fp has been found to correlate with dynamic contrast-
enhanced MRI in cervical cancer (17). Adenocarcinomas of 
the cervix exhibit a higher expression of vascular endothelial 
growth factor and thus a higher density of microvasculature 
in the tumor stroma (18) when compared to squamous cell 
cancer or the normal cervix uteri (19). This is in agreement 
with the higher Fp found in the adenocarcinomas in this 
study. On the other hand, the pseudodiffusion coefficient, 
D*, has been shown to correlate directly with the histologic 
microvessel count in the abdominal organs of healthy mice 
(20), as well as in a colon cancer xenograft model (21). 
Due to its instability in the conventional biexponential 
fitting approach, however, it is rarely investigated as a 
surrogate marker in clinical research. Somewhat surprisingly 
a lower D* was found in the adenocarcinomas in this study. 
Unfortunately, the histological specimens were not analyzed 
for microvessel density with a special staining. However, 
this lack will be addressed in a future study. It is likely 
that the low D* may be a reflection of abnormal blood flow 
due to the pathologic, irregular tumor vessels, which may 
behave differently from the physiological vasculature or 
vessels of other tumor entities. 
In summary, the parameter-free IVIM algorithm seems 
to yield a stable D* and Fp as potential surrogate markers 
of tumor microcirculation or architecture. It may thus be 
able to preoperatively assess the histologic type based on 
differences in IVIM parameters. The ability to discriminate 
between tumor types is of great clinical interest, since 
the Pap smear will often miss adenocarcinomas, which 
preferentially exhibit an endocervical growth pattern. The 
baseline treatment generally depends on staging and not 
tumor histology. However, the histopathological subtype 
is an independent predictor for outcome, patterns of 
failure after primary treatment, and response to specific 
treatments, in addition to other well-known prognostic 
factors like parametrial invasion, resection margins and 
nodal status (22). This in turn, has an impact on adjuvant 
treatment planning and oncological follow-up strategies (23, 
24). When combined with other techniques such as 1H MR 
spectroscopy, which has recently been shown to accurately 
predict the HPV genotype in cervical cancer (25), IVIM may 
be useful in the future for assessing the “MR fingerprint” of 
a cancer and predicting more accurately the histological and 
molecular tumor characteristics from the radiological data.
This study has two major limitations that need to be 
acknowledged. First, the IVIM analysis was performed on 
a single slice with the largest tumor diameter, and not on 
multiple slices evaluating the whole tumor volume. Since 
this method does not incorporate tumor heterogeneity 
but uses the averaged ROI content, it would probably not 
benefit from whole-tumor-analysis. However, our parameter-
free algorithm will be implemented for whole-tumor 
analysis in further studies. Second, only a small number 
of patients were analyzed. Nevertheless, the group size of 
this methodological pilot study was large enough to detect 
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significant differences in the b-value threshold between 
different types of cervical cancer. For the comparison 
between the histological types, the power of these 
findings is certainly low and an extended study including 
more patients to investigate IVIM parameters as possible 
surrogate markers will be undertaken. The small cohort 
size is a possible explanation for the lack of significant 
correlations with the FIGO-stage and tumor differentiation, 
both of which have been established before (6, 26). 
One of the major obstacles preventing the widespread 
clinical use of IVIM is the long duration of the scan protocol 
due to the need to acquire images at numerous b-values 
(27, 28). Based on the present data, it may be feasible to 
add two or three b-values (e.g., 30, 80, and 150 s/mm2) to 
a clinical pelvic DWI protocol, thus making it accessible for 
IVIM analysis. The accuracy of such a protocol would have 
to be evaluated in further studies.
In conclusion, the parameter-free IVIM approach is 
feasible in cervical cancer. The optimal b-value threshold, 
as well as the derived parameters D* and Fp, appear to 
depend on the histological type of tumor.
Supplementary Materials
The online-only Data Supplement is available with this 
article at https://doi.org/10.3348/kjr.2017.18.3.510.
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